Nintedanib
Aspartate aminotransferase elevated: case report
- 01.06.2019
- Case report
Erschienen in:
- Erschienen in
- Reactions Weekly | Ausgabe 1/2019
Auszug
In a retrospective study involving 142 patients, an 82-year-old1 man was described, who developed elevated aspartate aminotransferase levels following treatment with nintedanib [route not stated] for idiopathic pulmonary fibrosis (IPF). The man had been diagnosed with IPF and started receiving treatment with nintedanib 100mg twice a day. The dose was further increased to 150mg, twice a day and he subsequently developed grade 2 elevated aspartate aminotransferase levels [duration of treatment to reaction onset not stated]. The man's nintedanib was reduced [outcome not stated]. …
Anzeige
- Titel
-
Nintedanib
Aspartate aminotransferase elevated: case report - Publikationsdatum
- 01.06.2019
- Verlag
- Springer International Publishing
- Erschienen in
-
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051 - DOI
- https://doi.org/10.1007/s40278-019-64086-9
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.